Stockreport

TrialJectory and Precipio Partner to Provide Cancer Patients with First-of-its-Kind Diagnostic and Clinical Trial-Matching Service

Precipio, Inc.  (PRPO) 
US:NASDAQ Investor Relations: precipiodx.com/investors.html
PDF NEW YORK, Jan. 28, 2020 /PRNewswire/ -- TrialJectory, an AI-powered technology platform that empowers cancer patients to search and match with clinical trials, removing [Read more]